Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Immunity and Ageing is Scopus-indexed (Q1, CiteScore 10.9), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1742-4933Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology | 38 / 243 | 84th | Q1 |
| Aging | 7 / 42 | 84th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q1, CiteScore 10.9.
Immunity and Ageing is Q1 in Immunology (rank 38 of 243) and Q1 in Aging (rank 7 of 42), by CiteScore 2025.
Immunity and Ageing is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.9, which places it in quartile Q1 at the 84th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.298, quartile Q1, with an H-index of 71.
The publisher lists an article processing charge of about US$3,190 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Immunity and Ageing is published by BioMed Central Ltd. Its ISSN is 1742-4933.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Immunity and Ageing has an h-index of 82 and a 2-year mean of 8.91 citations per paper (OpenAlex). Its Scopus CiteScore is 10.9, quartile Q1. On 2-year citations it ranks #18 of 240 Scopus journals in Immunology.
Immunity and Ageing published 61 papers in 2025; its busiest recent year was 2024 with 90. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from China (29.6%), Germany (12.5%) and United States (10.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.